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Treated For Bovine Respiratory Disease
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Introduction
Bovine respiratory disease is the leading cause of cattle mortalities in U.S. feedlots. In 
addition to costs associated with death loss and medical treatments, cattle affected by 
respiratory disease typically have suboptimal performance. Lightweight calves coming 
into the feedlot are at high risk for respiratory disease due to the stress associated 
with weaning, transportation, feed and water deprivation, commingling, castration, 
and other factors. Calves often have no experience eating from feed bunks and may 
be unfamiliar with the types of feeds used in feedlots. At the same time, the cattle are 
susceptible to acidosis due to the concentrate-based diets that are fed, which also can 
have unfavorable effects on feed intake and performance. Moreover, symptoms of 
acute acidosis, which include poor appetite, increased respiration rate, lethargy, depres-
sion, loss of muscle tone, nasal and ocular discharge, and diarrhea, can be difficult to 
distinguish from clinical symptoms of respiratory disease. Therapies designed to address 
respiratory disease are generally ineffective for treating acidosis, inevitably leading to 
the perception that antibiotic treatments have only limited efficacy. Moreover, acido-
sis can increase susceptibility of cattle to respiratory disease. Acidosis is most logically 
dealt with through preventive measures. We hypothesized that Lactipro (MS Biotec; 
Wamego, KS), a source of the lactate-utilizing bacterium Megasphaera elsdenii, could 
decrease the incidence of feedlot acidosis in newly arrived feedlot calves. By preventing 
acidosis, we speculated that clinical symptoms similar to those associated with respira-
tory disease would be less prevalent, thus decreasing the number of animals inappro-
priately diagnosed and treated for respiratory disease. Our objective was to determine 
if dosing cattle with Lactipro at processing would decrease morbidity and mortality in 
lightweight calves after arrival at the feedlot. 
Experimental Procedures
Crossbred calves (504 bulls, 141 steers; initial body weight = 443 ± 11 lb) were 
received from Texas over a 2-week period in January (two loads per day on the Janu-
ary 14, 19, and 26). Cattle were given brome hay on arrival, and within 24 hours were 
weighed, vaccinated against common viral and clostridial diseases; dewormed, castrated 
(banded), treated with Micotil (Elanco Animal Health, Greenfield, IN), and given 
uniquely numbered ear tags. Cattle were randomly assigned to 1 of 2 treatments based 
on order through the processing chute. Our experimental treatments consisted of a 
negative control group (Control) and a group given a 100-mL oral dose of Lactipro at 
processing (Lactipro). Cattle were blocked by arrival date and randomly assigned to 
24 pens with 25 to 30 calves per pen. All calves received a common diet throughout 
the 64-day receiving period (Table 1). Cattle were monitored daily for clinical signs of 
illness, and animals determined to be sick were removed from their pen, taken to the 
processing area, and treated according to Kansas State University Beef Cattle Research 
Center standard operating procedures. Calves were categorized as sick if they exhib-
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ited signs of depression, decreased appetite, increased respiration rate, nasal and ocular 
discharge, and diarrhea. Therapuetic treatments for respiratory disease included Micotil 
for first-time antibiotic therapy, Baytril (Bayer Animal Health, Shawnee Mission, KS) 
for second-time antibiotic therapy, and LA-200 (Pfizer Animal Health, Whitehouse 
Station, NJ) for third-time antibiotic therapy.
Results and Discussion 
Health and performance are summarized in Table 2. Dosing calves with Lactipro at 
processing reduced the incidence of first-time antibiotic therapy by 31% (P = 0.02) and 
reduced the number of calves that required a second antibiotic therapy by 34%  
(P = 0.03). The number of animals requiring a third antibiotic therapy for bovine respi-
ratory disease did not differ between control and Lactipro groups (P = 0.36). Death 
loss also did not differ (P = 0.50) between treatments but was numerically lower for 
calves that received Lactipro. The decrease in antibiotic usage associated with Lactipro 
usage resulted in a 13.4% reduction (P = 0.01) in the cost of therapeutic treatments 
compared with the Control calves. Dosing calves with Lactipro improved dry matter 
intake (P = 0.01), average daily gain (P = 0.02), and feed efficiency (P = 0.05). 
Our contention is that the decreased incidence of respiratory disease associated with use 
of Lactipro likely is the result of avoiding ruminal acidosis, which can present clinical 
signs that are difficult to distinguish from bovine respiratory disease. As a result, misdi-
agnosis and unnecessary therapeutic treatments with antibiotics are less likely to occur. 
In addition, one of the important contributing causes of respiratory disease (i.e., acido-
sis) is less severe and less prevalent, ultimately decreasing the incidence of respiratory 
disease. Improved feed consumption in calves given Lactipro also may support greater 
immune function, thus allowing calves to cope with disease challenges more effectively. 
In this study, Lactipro provided an effective means of reducing the number of animals 
that required antibiotic treatment. We view this as positive, given the increased scrutiny 
relative to use of antibiotics in livestock production. 
Implications
A single oral dose of Lactipro at initial processing was an effective means of improving 
performance of high-risk calves as well as decreasing the number of calves that were 
treated for bovine respiratory disease after introduction into the feedlot. 
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Table 1. Composition of diet on a 100% dry matter basis
Ingredient, % of dry matter Receiving diet
Steam-flaked corn 36.32
Corn silage 45.00
Wet corn gluten feed 15.00
Supplement1 2.24
Feed additive premix2 1.44
Nutrient composition, %
Dry matter 53.5
Crude protein 12.0
Neutral detergent fiber 23.8
Calcium 0.70
Phosphorus 0.38
1 Formulated to provide 0.3% salt, 0.1 ppm Co, 10 ppm copper, 0.6 ppm iodine, 60 ppm manganese, 0.25 ppm 
selenium, 60 ppm zinc, 1,000 IU/lb vitamin A, and 10 IU/lb vitamin E in the total diet on a 100% dry matter 
basis.
2 Formulated to provide 200 mg Rumensin (Elanco Animal Health, Greenfield, IN) per animal daily.
Table 2. Receiving performance and health of high-risk calves orally drenched with 
Lactipro1 at initial processing
Item Control Lactipro SEM P-value
Initial weight, lb 440 446 10.8 0.23
Final weight, lb 557.5 579.1 9.3 <0.01
Average daily gain, lb 1.42 1.76 0.16 0.02
Dry matter intake, lb/day 9.53 10.16 0.37 0.01
Feed:gain, lb/lb 6.80 5.75 0.59 0.05
Total morbidity, % of cattle 37.7 26.4 4.81 0.02
Treatment for bovine respiratory disease, % of cattle
First-time treatment (Micotil2) 32.0 22.0 4.13 0.02
Second-time treatment (Baytril3) 17.4 11.5 2.09 0.03
Third-time treatment (LA-2004) 5.9 4.4 1.22 0.36
Death loss, % 4.9 3.8 1.13 0.50
Medication cost, $/calf 19.70 17.06 0.98 0.01
1 MS Biotec, Wamego, KS. 
2 Elanco Animal Health, Greenfield, IN.
3 Bayer Animal Health, Shawnee Mission, KS.
4 Pfizer Animal Health, Whitehouse Station, NJ.
